Skip to main content
Account

Table 2 IC50of MCF-7 TAX30 cells after 24-, 48-, and 72-h incubation with docetaxel formulated in Taxotere®, PCL, and PCL/Pluronic F68 nanoparticles at various drug concentrations

From: A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment

Incubation time (h)

IC50(μg/ml)

PCL/Pluronic F68 NPs

PCL NPs

Taxotere®

24

1.019

7.388

10.380

48

0.384

3.643

8.726

72

0.196

1.244

5.945

Navigation